ProQR Therapeutics N.V.

ProQR Therapeutics is a biotech company headquartered in Leiden, NL with offices in Palo Alto, CA focused on development of drugs to treat severe genetic disorders. Based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. Founded by industry veterans and based on what we believe is unique science, we strive to make a meaningful impact.

About ProQR

Our history
ProQR Therapeutics was founded in May 2012 in Leiden the Netherlands with the goal of developing a treatment for cystic fibrosis. The founding team - Daniel de Boer, Gerard Platenburg, Dinko Valerio and Henri Termeer - pulled together a team of motivated RNA and CF experts to work on a unique RNA therapy for CF. ProQR's innovative and promising technology was licensed from Massachusetts General Hospital in Boston, USA. Since then we have built a pipeline of programs that have the potential to treat other severe genetic diseases, including Leber’s congenital amaurosis, Usher syndrome, Fuchs endothelial corneal dystrophy, dystrophic epidermolysis bullosa and Alzheimer's disease. Currently ProQR counts over 125 people that work with passion and dedication on developing our therapies.

Our philosophy
At ProQR we have set ourselves the immense task of developing drugs that will potentially transform the lives of patients suffering from severe genetic diseases. To make this happen we demand the utmost of ourselves. We actively create a caring atmosphere filled with fun and joy, in which we love to work and maintain productive and happy lives. At ProQR we foster empowerment, self development, creativity and a sense of community. We are in this together!

We are a supportive, ingenious and persistent team that does things different. We're passionate and driven to change the lives of patients and their loved ones!

Think we are shooting for the stars? Well, we are! If you are up to this challenge and like to be part of our team, check out our vacancies.

You are now leaving ProQR Therapeutics

ProQR Therapeutics provides links to web sites of other organizations in order to provide visitors with certain information. A link does not constitute an endorsement of content, viewpoint, policies, products or services of that web site. Once you link to another web site not maintained by ProQR Therapeutics, you are subject to the terms and conditions of that web site, including but not limited to its privacy policy.

You will be redirected to

Click the link above to continue or CANCEL